Yeh, C., Chen, M., Chen, Y., Yang, C., Yen, C., Tzen, C., . . . Chen, J. (2017). A phase II trial of regorafenib in patients with metastatic and/or a unresectable gastrointestinal stromal tumor harboring secondary mutations of exon 17. Oncotarget.

Yeh, Chun-Nan, Ming-Huang Chen, Yen-Yang Chen, Ching-Yao Yang, Chueh-Chuan Yen, Chin-Yuan Tzen, Li-Tzong Chen, und Jen-Shi Chen. "A Phase II Trial of Regorafenib in Patients With Metastatic And/or a Unresectable Gastrointestinal Stromal Tumor Harboring Secondary Mutations of Exon 17." Oncotarget 2017.

Yeh, Chun-Nan, et al. "A Phase II Trial of Regorafenib in Patients With Metastatic And/or a Unresectable Gastrointestinal Stromal Tumor Harboring Secondary Mutations of Exon 17." Oncotarget 2017.